Categories
Coronavirus News

Allergic Rhinitis Market To Witness A CAGR Of 7.5% Between 2024

Market Report Summary 

  • Market – Allergic Rhinitis Market 
  • Market Value – US$ 7,000 Mn in 2024 
  • Market CAGR Value – 7.5% in 2024 
  • Market Forecast Year – 2020 to 2030 

For Full Information ->  Click Here 

Read Full Press Release Below

“Technological advancements in the medical world and rising prevalence of foodborne diseases will primarily build the market for allergic rhinitis treatment globally. Secondarily, strategic partnerships and synergies between big brands, soaring usage of second-generation multiplex immunoassay, and augmenting R&D activities in life sciences and molecular diagnostics will support the market surge within the next few years.

Over 2016-2020, the global AR treatment market will reach US$ 14 Bn, which will further take a leap to US$ 16.038 Bn by the end of 2024. Over 2016-2024, the market is likely to see impressive growth at a healthy CAGR of 7.5%.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12154

Company Profiles

  • Merck & Co.
  • Boehringer Ingelheim
  • AstraZeneca
  • GlaxoSmithKline PLC
  • Sanofi S.A.
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Alcon (Novartis AG)

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12154

– Market Research Expert, Life Sciences & Transformational Health, Persistence Market Research.

According to Persistence Market Research’s recent report titled “Global Allergic Rhinitis Treatment Market: Industry Analysis and Forecast, 2016–2024,” key market competitors have embraced different strategic moves in order to strengthen their positions in the global allergic rhinitis treatment marketplace. These activities, according to Persistence Market Research, will boost the overall status of the market in near future.

  • Merck & Co. and Johnson & Johnson are concentrating on new product development, such as nasal sprays.
  • Boehringer Ingelheim will continue to contribute a major share to the market through an increased focus on R&D and a strong distribution network.
  • Sanofi S.A. is also focusing more on increasing R&D investments directed to expanded sales.
  • In addition to growing R&D efforts, AstraZeneca is also emphasizing on innovation of technologically advanced products and acquisition of selective regional players.
  • GlaxoSmithKline PLC and Alcon (Novartis AG) are prioritising cost-effective product development for long-term profits; Alcon specifically aims to tap into emerging markets.
  • Acquisition of players from the same segment and different region will be a key strategy of Teva Pharmaceutical Industries Ltd., which targets production capacity expansion.

By disease type, perennial AR segment will remain dominant with around 47% market value share in 2024, gaining around 123 BPS throughout the forecast period. On the other hand, despite losing over 30 BPS over 2016-2024, occupational AR will continue to be the second largest segment with over 35% revenue share at the end of the assessment period. While the revenues of the former are expected to surpass US$ 7.0 Bn, the latter will possibly exceed a value of US$ 5.0 Bn by the end of 2024.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/12154

By treatment type, immunotherapy treatment segment is expected to be the fastest growing segment over the forecast owing to introduction of new immunotherapy based products, followed by antihistamines segment. However, antihistamines will continue to be the leading treatment type segment with over 50% share in 2024, followed by corticosteroids with over 31% share.

Based on route of administration, oral route of administration segment will cover nearly half of the market in terms of value, whereas nasal route of administration segment is anticipated to capture around 38% share of the total market value in 2024. Intravenous segment is foreseen to witness a higher CAGR compared to others, which can uplift the sales revenues of this segment to cross US$ 1.25 Bn in 2024.

On the basis of distribution channel, retail pharmacies will account for higher revenues than hospital pharmacies throughout the assessed period. Retail pharmacy revenues are likely to surpass US$ 7.0 Bn, growing at the fastest CAGR of 3.9% over 2016-2024. Whereas, hospital pharmacies will reach over US$ 5.0 Bn, accounting for around 31% share of the market value in 2024.

As per the geographical assessment of the global allergic rhinitis treatment market, North America will continue to capture the maximum revenue share over the 10-year tenure. With over 63% value share by 2024-end, this region is likely to surpass US$ 10.0 Bn in terms of revenues. European market will possibly attract the revenues worth US$ 3.68 Bn by 2024 end, contributing over 22% share of the market size. The third key region i.e. APAC is estimated to reach over US$ 1.27 Bn in 2024.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish Kolte
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

 

Categories
Coronavirus News

The Allergic Rhinitis Market To Line Up With The Technological Up Gradations, Reach US$ 7,000 Mn

Market Report Summary 

  • Market – Allergic Rhinitis Market 
  • Market Value – US$ 7,000 Mn in 2024 
  • Market CAGR Value – 7.5% in 2024 
  • Market Forecast Year – 2020 to 2030 

For Full Information ->  Click Here 

Read Full Press Release Below

“Technological advancements in the medical world and rising prevalence of foodborne diseases will primarily build the market for allergic rhinitis treatment globally. Secondarily, strategic partnerships and synergies between big brands, soaring usage of second-generation multiplex immunoassay, and augmenting R&D activities in life sciences and molecular diagnostics will support the market surge within the next few years.

Over 2016-2020, the global AR treatment market will reach US$ 14 Bn, which will further take a leap to US$ 16.038 Bn by the end of 2024. Over 2016-2024, the market is likely to see impressive growth at a healthy CAGR of 7.5%.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12154

Company Profiles

  • Merck & Co.
  • Boehringer Ingelheim
  • AstraZeneca
  • GlaxoSmithKline PLC
  • Sanofi S.A.
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Alcon (Novartis AG)

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12154

– Market Research Expert, Life Sciences & Transformational Health, Persistence Market Research.

According to Persistence Market Research’s recent report titled “Global Allergic Rhinitis Treatment Market: Industry Analysis and Forecast, 2016–2024,” key market competitors have embraced different strategic moves in order to strengthen their positions in the global allergic rhinitis treatment marketplace. These activities, according to Persistence Market Research, will boost the overall status of the market in near future.

  • Merck & Co. and Johnson & Johnson are concentrating on new product development, such as nasal sprays.
  • Boehringer Ingelheim will continue to contribute a major share to the market through an increased focus on R&D and a strong distribution network.
  • Sanofi S.A. is also focusing more on increasing R&D investments directed to expanded sales.
  • In addition to growing R&D efforts, AstraZeneca is also emphasizing on innovation of technologically advanced products and acquisition of selective regional players.
  • GlaxoSmithKline PLC and Alcon (Novartis AG) are prioritising cost-effective product development for long-term profits; Alcon specifically aims to tap into emerging markets.
  • Acquisition of players from the same segment and different region will be a key strategy of Teva Pharmaceutical Industries Ltd., which targets production capacity expansion.

By disease type, perennial AR segment will remain dominant with around 47% market value share in 2024, gaining around 123 BPS throughout the forecast period. On the other hand, despite losing over 30 BPS over 2016-2024, occupational AR will continue to be the second largest segment with over 35% revenue share at the end of the assessment period. While the revenues of the former are expected to surpass US$ 7.0 Bn, the latter will possibly exceed a value of US$ 5.0 Bn by the end of 2024.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/12154

By treatment type, immunotherapy treatment segment is expected to be the fastest growing segment over the forecast owing to introduction of new immunotherapy based products, followed by antihistamines segment. However, antihistamines will continue to be the leading treatment type segment with over 50% share in 2024, followed by corticosteroids with over 31% share.

Based on route of administration, oral route of administration segment will cover nearly half of the market in terms of value, whereas nasal route of administration segment is anticipated to capture around 38% share of the total market value in 2024. Intravenous segment is foreseen to witness a higher CAGR compared to others, which can uplift the sales revenues of this segment to cross US$ 1.25 Bn in 2024.

On the basis of distribution channel, retail pharmacies will account for higher revenues than hospital pharmacies throughout the assessed period. Retail pharmacy revenues are likely to surpass US$ 7.0 Bn, growing at the fastest CAGR of 3.9% over 2016-2024. Whereas, hospital pharmacies will reach over US$ 5.0 Bn, accounting for around 31% share of the market value in 2024.

As per the geographical assessment of the global allergic rhinitis treatment market, North America will continue to capture the maximum revenue share over the 10-year tenure. With over 63% value share by 2024-end, this region is likely to surpass US$ 10.0 Bn in terms of revenues. European market will possibly attract the revenues worth US$ 3.68 Bn by 2024 end, contributing over 22% share of the market size. The third key region i.e. APAC is estimated to reach over US$ 1.27 Bn in 2024.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish Kolte
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

 

Categories
All News

Allergic Rhinitis Market Size 2020 | Analysis, Trends, Top Manufacturers, Growth, Scope, Opportunities and Forecast to 2027

New Jersey, United States,- The Allergic Rhinitis Market report provides an in-depth analysis of the current and future state of the Allergic Rhinitis industry. The Allergic Rhinitis Market Report presents emerging trends and market dynamics regarding drivers, opportunities, and challenges. The report covers the details of suppliers, consumers, and the level of competition. It also includes Allergic Rhinitis Market Size, Revenue, Share, Industry Growth Rate, and Revenue. The Allergic Rhinitis market report has an essential list of key aspects of Allergic Rhinitis that includes leading market players along with their profiles and key financial data.

The most recent Allergic Rhinitis market report has extensive documentation of this industry while also showing the consumption and production patterns. The report provides information on key drivers, challenges, threats, and opportunities that are influencing market dynamics. It also includes Porter’s Five Forces Analysis to examine the industry’s competitive matrix.

The study draws attention to various trading tactics that can be used to generate returns. However, due to the recent COVID-19 outbreak, the market will have some uncertainties. The research, therefore, focuses on the impact of the coronavirus pandemic on the industry scenario over the forecast period and suggests a coping mechanism for better results.

The report provides an in-depth analysis of the major market players along with their business overview, expansion plans, and strategies. The main actors examined in the report are:

  • Glaxosmithkline
  • Sanofi
  • Alk-abell
  • Meda Pharmaceuticals
  • Merck
  • Boehringer Ingelheim
  • Astrazeneca
  • Johnson & Johnson
  • Teva
  • Alcon (novartis)

    The report covers the global Allergic Rhinitis Market size in terms of value chain, production and consumption quota. The report considers 2017-2018 as historical years, 2019 as the base year and the forecast calendar 2020-2027. It also covers the market breakdown in terms of top manufacturers, key regions, types of products offered in the market and range of applications.

    Allergic Rhinitis Market by Type Segments:

  • Solid
  • Liquid

    Allergic Rhinitis Market by Application Segments:

  • Hospital
  • Clinic
  • Research

    Allergic Rhinitis Market by Regional Segments:

    The chapter on regional segmentation details the regional aspects of the Allergic Rhinitis market. This chapter explains the regulatory framework that is likely to impact the overall market. It highlights the political scenario in the market and anticipates its influence on the Allergic Rhinitis market.

    • The Middle East and Africa (GCC Countries and Egypt)
    • North America (the United States, Mexico, and Canada)
    • South America (Brazil etc.)
    • Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
    • Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

    Report Highlights

    • Comprehensive pricing analysis on the basis of product, application, and regional segments
    • The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the Allergic Rhinitis market
    • Deep insights about regulatory and investment scenarios of the Allergic Rhinitis market
    • Analysis of market effect factors and their impact on the forecast and outlook of the Allergic Rhinitis market
    • A roadmap of growth opportunities available in the Allergic Rhinitis market with the identification of key factors
    • The exhaustive analysis of various trends of the Allergic Rhinitis market to help identify market developments

    Table of Contents

    • Report Overview: It includes six chapters, viz. research scope, major manufacturers covered, market segments by type, Allergic Rhinitis market segments by application, study objectives, and years considered.
    • Global Growth Trends: There are three chapters included in this section, i.e. industry trends, the growth rate of key producers, and production analysis.
    • Allergic Rhinitis Market Share by Manufacturer: Here, production, revenue, and price analysis by the manufacturer are included along with other chapters such as expansion plans and merger and acquisition, products offered by key manufacturers, and areas served and headquarters distribution.
    • Market Size by Type: It includes analysis of price, production value market share, and production market share by type.
    • Market Size by Application: This section includes Allergic Rhinitis market consumption analysis by application.
    • Profiles of Manufacturers: Here, leading players of the Allergic Rhinitis market are studied based on sales area, key products, gross margin, revenue, price, and production.
    • Allergic Rhinitis Market Value Chain and Sales Channel Analysis: It includes customer, distributor, Allergic Rhinitis market value chain, and sales channel analysis.
    • Market Forecast – Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

    Get More Information @ https://www.marketresearchintellect.com/product/global-allergic-rhinitis-market-size-and-forcast/

    Thank you for reading our report. Please contact us to learn more about the report and the customization options. Our team will ensure that the report meets your requirements.

    About Us:

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

    Contact Us:

    Mr. Steven Fernandes

    Market Research Intellect

    New Jersey ( USA )

    Tel: +1-650-781-4080

    Website – https://www.marketresearchintellect.com/